Hassibullah Akeefe

USPTO Granted Patents = 12 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 2)

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 100(Granted Patents)

Location History:

Antioch, CA (US) (2008)
San Ramon, CA (US) (2008 - 2023)

Company Filing History:

Eli Lilly and Company

Biomarin Pharmaceutical Inc.

patents

Years Active: 2008-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11739345 - Methods of treating phenylketonuria (2023-08-29),

2. 8637460 - Methods and apparatus for creating particle derivatives of HDL with reduced lipid content (2014-01-28),

3. 8506968 - SARS vaccine compositions and methods of making and using them (2013-08-13),

4. 8435531 - Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response (2013-05-07),

5. 8268787 - Methods and apparatus for creating particle derivatives of HDL with reduced lipid content (2012-09-18),

6. 8048015 - Methods and apparatus for creating particle derivatives of HDL with reduced lipid content (2011-11-01),

7. 8030281 - Methods and apparatus for creating particle derivatives of HDL with reduced lipid content (2011-10-04),

8. 7740872 - Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response (2010-06-22),

9. 7393826 - Methods and apparatus for creating particle derivatives of HDL with reduced lipid content (2008-07-01),

10. 7375191 - Methods and apparatus for creating particle derivatives of HDL with reduced lipid content (2008-05-20),

11. 7361739 - Methods and apparatus for creating particle derivatives of HDL with reduced lipid content (2008-04-22),

12. 7361360 - Method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response (2008-04-22),

Title: Innovations of Hassibullah Akeefe

Introduction

Hassibullah Akeefe is a notable inventor based in San Ramon, CA, with a remarkable portfolio of 12 patents. His work primarily focuses on advancements in medical treatments and lipid management, showcasing his commitment to improving health outcomes.

Latest Patents

Among his latest patents, Akeefe has developed methods for treating phenylketonuria. This invention provides methods for normalizing levels of amino acids, neurotransmitters, and neurotransmitter metabolites in individuals affected by this condition. Another significant patent involves methods and apparatus for creating particle derivatives of HDL with reduced lipid content. This invention aims to produce HDL derivatives that can effectively bind cholesterol, thereby enhancing cellular cholesterol efflux and reducing cholesterol levels in various bodily systems. This method is particularly beneficial for treating atherogenic vascular disease and can be combined with other therapies.

Career Highlights

Throughout his career, Akeefe has made significant contributions to the field of lipid research and treatment. His innovative approaches have positioned him as a key figure in the development of therapies aimed at managing cholesterol levels and related health issues.

Collaborations

Akeefe has collaborated with notable professionals in his field, including Marc Bellotti and H. Bryan Brewer. These partnerships have further enriched his research and development efforts.

Conclusion

Hassibullah Akeefe's contributions to medical innovation, particularly in the treatment of phenylketonuria and cholesterol management, highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in health and wellness.

This text is generated by artificial intelligence and may not be accurate.